CNS vs HASI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CNS

34.6
AI Score
VS
HASI Wins

HASI

43.4
AI Score

Investment Advisor Scores

CNS

35score
Recommendation
SELL

HASI

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS HASI Winner
Revenue 94.41M 359.48M HASI
Net Income 29.96M 203.14M HASI
Net Margin 31.7% 56.5% HASI
ROE 9.9% 7.4% CNS
ROA 6.7% 2.1% CNS
Total Assets 450.12M 9.63B HASI
Cash 193.73M 102.29M CNS

Relative Price Performance (Last 90 Days)

CNS 1M: +5.6% · 3M: -15.1% HASI 1M: +7.6% · 3M: -6.2%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $72.72

HASI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.5 · Price: $39.73

Fundamentals Snapshot

Metric CNS HASI
Market Cap — —
Forward P/E 19.6 17.6
Trailing P/E 22.7 35.8
Revenue (TTM) — —
Revenue Growth 0.1% -0.5%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% -1.6%
EPS 3.25 1.09
Dividend Yield 0.04% 0.04%

Frequently Asked Questions

Based on our detailed analysis, HASI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.